Mark R. Brunswick, Ph.D.
« Back to Team
Senior Vice President Regulatory Affairs
- Dr. Brunswick has over 35 years of senior positions in Regulated Industry including over 9 years in the US FDA, Center for Biologics, Division of Monoclonal Antibodies
- Prior to joining Sorrento, Dr. Brunswick was Head of Regulatory Affairs and Quality at Sophiris Bio, a company developing a drug for benign prostatic hyperplasia and prostate cancer. Prior to that he was the head of Regulatory Affairs at Arena Pharmaceuticals specializing in therapies directed at G Protein receptors
- Dr. Brunswick led the regulatory group at Elan Pharmaceuticals concentrating on Alzheimer Disease and the pain compound, ziconotide
- B.S. and Ph.D.